| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.47 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |